IndraLab
Statements
sparser
"Segmental duplications (SDs), which are considered a common phenomenon and account for approximately 7% (or 218 Mbp) of the human genome [ xref ], have been reported to be associated with the formation of chimeric fusion genes, such as BCR::ABL1 through t(9;22)(q34;q11.2) [ xref ] and RUNX1::USP42 through ins(21;7)(q22;p15p22) [ xref ], in myeloid malignancies."
sparser
"In this latter patient (case 7), the recipient origin of the MS 171 months after the SCT was confirmed by the identification of an NF1 polymorphism in both pre‐ and post‐transplant samples, but the RUNX1::USP42 fusion in the MS could not be analyzed in the pre‐transplant BMB for technical reasons."
sparser
"Many of the remaining pediatric AML cases had structural variations leading to in-frame fusion events (e.g., MLLT10 fusions not with KMT2A or PICALM or RUNX1::USP42 ) 20.21 that likely drive AML, but that are not recurrent enough to warrant designation as a distinct molecular category without interrogating additional datasets."
sparser
"The remaining patients harbored already reported fusions that do not impact our current treatment protocols ( STIL::TAL1, RBM15::MKL1, PICALM::MLLT10 ) and novel fusions recently reported in the literature with potential or clinical impact in therapeutic protocols [ P2RY8::CRLF2, MEF2D::BCL9, MEF2D::CSF1R, ETV6::ABL1, TCF3::ZNF384, PAX5::NOL4L, RUNX1::CBFA2T3, RUNX1::USP42 , and TBL1XR1::TP63 ( xref )]."
sparser
"In the same line, some of the most recurrent fusion genes in pediatric leukemia were found in our cohort ( ETV6::RUNX1, STIL::TAL1, KMT2A -rearrangements, RUNX1::RUNX1T1, BCR::ABL1 ), as well as other novel rearrangements described, most of them associated with BCP-ALL B-other subtypes ( MEF2D::BCL9, MEF2D::CSF1R, ETV6::ABL1, TCF3::ZNF384, and PAX5::NOL4L ) or to rare and/or recent AML fusions reported in the literature ( RUNX1::CBFA2T3, RBM15::MKL1, RUNX1::USP42, and TBL1XR1::TP63 ) ( xref ; xref ; xref )."
sparser
"Whole-genome sequencing identified cytogenetically cryptic structural variants in 13 patients, including complex or cryptic chromosomal translocations involving the inv(16)(p13.1q22) fusion gene CBFB–MYH11 in 2 patients, the t(7;21) (p22;q22) fusion gene USP42–RUNX1 in 1 patient, and 10 rearrangements involving KMT2A , all of which were verified with the use of orthogonal methods ( xref and xref , xref , and xref in the xref )."
sparser
"The patients in the remaining cluster, carried various nonrecurrent rearrangements, including BCL11B rearrangements (n=2), CBFB-MYH11 (n=2), ETV6-MECOM (n=1), KMT2A-MLLT10 (n=1), MECOM (n=1), NUP98-HOXA13 (n=1), SFPQ-ZFP36L2 (n=1), MED12-HOXA9 (n=1), PIM1-BRD1 (n=1), CBFA2T3-GLIS2 (n=1), PICALM-MLLT10 (n=1), RUNX1-USP42 (n=1)."
sparser
"Of note, del(5q) occurs as a secondary abnormality in at least two subtypes of AML with cryptic abnormalities: t(5;11)(q35;p15)/ NUP98-NSD1 and the rare t(7;21)(p22;q22)/ RUNX1-USP42 , thus emphasizing the need for a complete cytogenetic and molecular screening of such cases [ xref , xref , xref ]."